Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial Article Swipe
Byoung Chul Cho
,
Dong‐Wan Kim
,
Alexander I. Spira
,
Jorge Gómez
,
Eric B. Haura
,
Sang‐We Kim
,
Rachel E. Sanborn
,
Eun Kyung Cho
,
Ki Hyeong Lee
,
Anna Minchom
,
Jong Seok Lee
,
Ji‐Youn Han
,
Misako Nagasaka
,
Joshua K. Sabari
,
Sai‐Hong Ignatius Ou
,
Patricia Lorenzini
,
Joshua Bauml
,
Joshua C. Curtin
,
Amy Roshak
,
Grace Gao
,
John Xie
,
Meena Thayu
,
Roland E. Knoblauch
,
Keunchil Park
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1038/s41591-023-02554-7
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1038/s41591-023-02554-7
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41591-023-02554-7
- https://www.nature.com/articles/s41591-023-02554-7.pdf
- OA Status
- hybrid
- Cited By
- 86
- References
- 51
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4386741480
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4386741480Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41591-023-02554-7Digital Object Identifier
- Title
-
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trialWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-09-14Full publication date if available
- Authors
-
Byoung Chul Cho, Dong‐Wan Kim, Alexander I. Spira, Jorge Gómez, Eric B. Haura, Sang‐We Kim, Rachel E. Sanborn, Eun Kyung Cho, Ki Hyeong Lee, Anna Minchom, Jong Seok Lee, Ji‐Youn Han, Misako Nagasaka, Joshua K. Sabari, Sai‐Hong Ignatius Ou, Patricia Lorenzini, Joshua Bauml, Joshua C. Curtin, Amy Roshak, Grace Gao, John Xie, Meena Thayu, Roland E. Knoblauch, Keunchil ParkList of authors in order
- Landing page
-
https://doi.org/10.1038/s41591-023-02554-7Publisher landing page
- PDF URL
-
https://www.nature.com/articles/s41591-023-02554-7.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://www.nature.com/articles/s41591-023-02554-7.pdfDirect OA link when available
- Concepts
-
Medicine, Osimertinib, Oncology, Internal medicine, Clinical endpoint, Lung cancer, Epidermal growth factor receptor, Cohort, Progression-free survival, Prospective cohort study, Cancer, Clinical trial, Chemotherapy, ErlotinibTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
86Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 46, 2024: 35, 2023: 5Per-year citation counts (last 5 years)
- References (count)
-
51Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4386741480 |
|---|---|
| doi | https://doi.org/10.1038/s41591-023-02554-7 |
| ids.doi | https://doi.org/10.1038/s41591-023-02554-7 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37710001 |
| ids.openalex | https://openalex.org/W4386741480 |
| fwci | 29.01424876 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000188 |
| mesh[1].descriptor_ui | D002289 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | drug therapy |
| mesh[1].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[2].qualifier_ui | Q000235 |
| mesh[2].descriptor_ui | D002289 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | genetics |
| mesh[2].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[3].qualifier_ui | Q000188 |
| mesh[3].descriptor_ui | D008175 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | drug therapy |
| mesh[3].descriptor_name | Lung Neoplasms |
| mesh[4].qualifier_ui | Q000235 |
| mesh[4].descriptor_ui | D008175 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | genetics |
| mesh[4].descriptor_name | Lung Neoplasms |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D011446 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Prospective Studies |
| mesh[6].qualifier_ui | Q000627 |
| mesh[6].descriptor_ui | D047428 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | therapeutic use |
| mesh[6].descriptor_name | Protein Kinase Inhibitors |
| mesh[7].qualifier_ui | Q000494 |
| mesh[7].descriptor_ui | D047428 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | pharmacology |
| mesh[7].descriptor_name | Protein Kinase Inhibitors |
| mesh[8].qualifier_ui | Q000235 |
| mesh[8].descriptor_ui | D009154 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | genetics |
| mesh[8].descriptor_name | Mutation |
| mesh[9].qualifier_ui | Q000627 |
| mesh[9].descriptor_ui | D000814 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | therapeutic use |
| mesh[9].descriptor_name | Aniline Compounds |
| mesh[10].qualifier_ui | Q000235 |
| mesh[10].descriptor_ui | D066246 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | genetics |
| mesh[10].descriptor_name | ErbB Receptors |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | Q000188 |
| mesh[12].descriptor_ui | D002289 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | drug therapy |
| mesh[12].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[13].qualifier_ui | Q000235 |
| mesh[13].descriptor_ui | D002289 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | genetics |
| mesh[13].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[14].qualifier_ui | Q000188 |
| mesh[14].descriptor_ui | D008175 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | drug therapy |
| mesh[14].descriptor_name | Lung Neoplasms |
| mesh[15].qualifier_ui | Q000235 |
| mesh[15].descriptor_ui | D008175 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | genetics |
| mesh[15].descriptor_name | Lung Neoplasms |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D011446 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Prospective Studies |
| mesh[17].qualifier_ui | Q000627 |
| mesh[17].descriptor_ui | D047428 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | therapeutic use |
| mesh[17].descriptor_name | Protein Kinase Inhibitors |
| mesh[18].qualifier_ui | Q000494 |
| mesh[18].descriptor_ui | D047428 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | pharmacology |
| mesh[18].descriptor_name | Protein Kinase Inhibitors |
| mesh[19].qualifier_ui | Q000235 |
| mesh[19].descriptor_ui | D009154 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | genetics |
| mesh[19].descriptor_name | Mutation |
| mesh[20].qualifier_ui | Q000627 |
| mesh[20].descriptor_ui | D000814 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | therapeutic use |
| mesh[20].descriptor_name | Aniline Compounds |
| mesh[21].qualifier_ui | Q000235 |
| mesh[21].descriptor_ui | D066246 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | genetics |
| mesh[21].descriptor_name | ErbB Receptors |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D006801 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Humans |
| mesh[23].qualifier_ui | Q000188 |
| mesh[23].descriptor_ui | D002289 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | drug therapy |
| mesh[23].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[24].qualifier_ui | Q000235 |
| mesh[24].descriptor_ui | D002289 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | genetics |
| mesh[24].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[25].qualifier_ui | Q000188 |
| mesh[25].descriptor_ui | D008175 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | drug therapy |
| mesh[25].descriptor_name | Lung Neoplasms |
| mesh[26].qualifier_ui | Q000235 |
| mesh[26].descriptor_ui | D008175 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | genetics |
| mesh[26].descriptor_name | Lung Neoplasms |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D011446 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Prospective Studies |
| mesh[28].qualifier_ui | Q000627 |
| mesh[28].descriptor_ui | D047428 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | therapeutic use |
| mesh[28].descriptor_name | Protein Kinase Inhibitors |
| mesh[29].qualifier_ui | Q000494 |
| mesh[29].descriptor_ui | D047428 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | pharmacology |
| mesh[29].descriptor_name | Protein Kinase Inhibitors |
| mesh[30].qualifier_ui | Q000235 |
| mesh[30].descriptor_ui | D009154 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | genetics |
| mesh[30].descriptor_name | Mutation |
| mesh[31].qualifier_ui | Q000627 |
| mesh[31].descriptor_ui | D000814 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | therapeutic use |
| mesh[31].descriptor_name | Aniline Compounds |
| mesh[32].qualifier_ui | Q000235 |
| mesh[32].descriptor_ui | D066246 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | genetics |
| mesh[32].descriptor_name | ErbB Receptors |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D006801 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Humans |
| mesh[34].qualifier_ui | Q000188 |
| mesh[34].descriptor_ui | D002289 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | drug therapy |
| mesh[34].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[35].qualifier_ui | Q000235 |
| mesh[35].descriptor_ui | D002289 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | genetics |
| mesh[35].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[36].qualifier_ui | Q000188 |
| mesh[36].descriptor_ui | D008175 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | drug therapy |
| mesh[36].descriptor_name | Lung Neoplasms |
| mesh[37].qualifier_ui | Q000235 |
| mesh[37].descriptor_ui | D008175 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | genetics |
| mesh[37].descriptor_name | Lung Neoplasms |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D011446 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Prospective Studies |
| mesh[39].qualifier_ui | Q000627 |
| mesh[39].descriptor_ui | D047428 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | therapeutic use |
| mesh[39].descriptor_name | Protein Kinase Inhibitors |
| mesh[40].qualifier_ui | Q000494 |
| mesh[40].descriptor_ui | D047428 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | pharmacology |
| mesh[40].descriptor_name | Protein Kinase Inhibitors |
| mesh[41].qualifier_ui | Q000235 |
| mesh[41].descriptor_ui | D009154 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | genetics |
| mesh[41].descriptor_name | Mutation |
| mesh[42].qualifier_ui | Q000627 |
| mesh[42].descriptor_ui | D000814 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | therapeutic use |
| mesh[42].descriptor_name | Aniline Compounds |
| mesh[43].qualifier_ui | Q000235 |
| mesh[43].descriptor_ui | D066246 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | genetics |
| mesh[43].descriptor_name | ErbB Receptors |
| type | article |
| title | Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial |
| biblio.issue | 10 |
| biblio.volume | 29 |
| biblio.last_page | 2585 |
| biblio.first_page | 2577 |
| topics[0].id | https://openalex.org/T10417 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Lung Cancer Treatments and Mutations |
| topics[1].id | https://openalex.org/T11067 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9973999857902527 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Colorectal Cancer Treatments and Studies |
| topics[2].id | https://openalex.org/T10696 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9897000193595886 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Gastric Cancer Management and Outcomes |
| is_xpac | False |
| apc_list.value | 9750 |
| apc_list.currency | EUR |
| apc_list.value_usd | 11690 |
| apc_paid.value | 9750 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 11690 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8234178423881531 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2777626846 |
| concepts[1].level | 5 |
| concepts[1].score | 0.8083077669143677 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q21506464 |
| concepts[1].display_name | Osimertinib |
| concepts[2].id | https://openalex.org/C143998085 |
| concepts[2].level | 1 |
| concepts[2].score | 0.7202231884002686 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[2].display_name | Oncology |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6851295232772827 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C203092338 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6771841049194336 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1340863 |
| concepts[4].display_name | Clinical endpoint |
| concepts[5].id | https://openalex.org/C2776256026 |
| concepts[5].level | 2 |
| concepts[5].score | 0.6540313959121704 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q47912 |
| concepts[5].display_name | Lung cancer |
| concepts[6].id | https://openalex.org/C2779438470 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5419811010360718 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q424401 |
| concepts[6].display_name | Epidermal growth factor receptor |
| concepts[7].id | https://openalex.org/C72563966 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4838756322860718 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[7].display_name | Cohort |
| concepts[8].id | https://openalex.org/C2780739268 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4759490191936493 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2112244 |
| concepts[8].display_name | Progression-free survival |
| concepts[9].id | https://openalex.org/C188816634 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4193485975265503 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2113324 |
| concepts[9].display_name | Prospective cohort study |
| concepts[10].id | https://openalex.org/C121608353 |
| concepts[10].level | 2 |
| concepts[10].score | 0.40937045216560364 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[10].display_name | Cancer |
| concepts[11].id | https://openalex.org/C535046627 |
| concepts[11].level | 2 |
| concepts[11].score | 0.4028364419937134 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[11].display_name | Clinical trial |
| concepts[12].id | https://openalex.org/C2776694085 |
| concepts[12].level | 2 |
| concepts[12].score | 0.26424580812454224 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[12].display_name | Chemotherapy |
| concepts[13].id | https://openalex.org/C2778087573 |
| concepts[13].level | 4 |
| concepts[13].score | 0.23109886050224304 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q418369 |
| concepts[13].display_name | Erlotinib |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8234178423881531 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/osimertinib |
| keywords[1].score | 0.8083077669143677 |
| keywords[1].display_name | Osimertinib |
| keywords[2].id | https://openalex.org/keywords/oncology |
| keywords[2].score | 0.7202231884002686 |
| keywords[2].display_name | Oncology |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.6851295232772827 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/clinical-endpoint |
| keywords[4].score | 0.6771841049194336 |
| keywords[4].display_name | Clinical endpoint |
| keywords[5].id | https://openalex.org/keywords/lung-cancer |
| keywords[5].score | 0.6540313959121704 |
| keywords[5].display_name | Lung cancer |
| keywords[6].id | https://openalex.org/keywords/epidermal-growth-factor-receptor |
| keywords[6].score | 0.5419811010360718 |
| keywords[6].display_name | Epidermal growth factor receptor |
| keywords[7].id | https://openalex.org/keywords/cohort |
| keywords[7].score | 0.4838756322860718 |
| keywords[7].display_name | Cohort |
| keywords[8].id | https://openalex.org/keywords/progression-free-survival |
| keywords[8].score | 0.4759490191936493 |
| keywords[8].display_name | Progression-free survival |
| keywords[9].id | https://openalex.org/keywords/prospective-cohort-study |
| keywords[9].score | 0.4193485975265503 |
| keywords[9].display_name | Prospective cohort study |
| keywords[10].id | https://openalex.org/keywords/cancer |
| keywords[10].score | 0.40937045216560364 |
| keywords[10].display_name | Cancer |
| keywords[11].id | https://openalex.org/keywords/clinical-trial |
| keywords[11].score | 0.4028364419937134 |
| keywords[11].display_name | Clinical trial |
| keywords[12].id | https://openalex.org/keywords/chemotherapy |
| keywords[12].score | 0.26424580812454224 |
| keywords[12].display_name | Chemotherapy |
| keywords[13].id | https://openalex.org/keywords/erlotinib |
| keywords[13].score | 0.23109886050224304 |
| keywords[13].display_name | Erlotinib |
| language | en |
| locations[0].id | doi:10.1038/s41591-023-02554-7 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S203256638 |
| locations[0].source.issn | 1078-8956, 1546-170X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1078-8956 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Nature Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310319908 |
| locations[0].source.host_organization_name | Nature Portfolio |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.nature.com/articles/s41591-023-02554-7.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Nature Medicine |
| locations[0].landing_page_url | https://doi.org/10.1038/s41591-023-02554-7 |
| locations[1].id | pmid:37710001 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Nature medicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37710001 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10579096 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10579096/pdf/41591_2023_Article_2554.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Nat Med |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10579096 |
| locations[3].id | pmh:oai:s-space.snu.ac.kr:10371/195815 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401345 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Seoul National University Open Repository (Seoul National University) |
| locations[3].source.host_organization | https://openalex.org/I139264467 |
| locations[3].source.host_organization_name | Seoul National University |
| locations[3].source.host_organization_lineage | https://openalex.org/I139264467 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://hdl.handle.net/10371/195815 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5064697305 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5562-270X |
| authorships[0].author.display_name | Byoung Chul Cho |
| authorships[0].countries | KR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I193775966 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea |
| authorships[0].institutions[0].id | https://openalex.org/I193775966 |
| authorships[0].institutions[0].ror | https://ror.org/01wjejq96 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I193775966 |
| authorships[0].institutions[0].country_code | KR |
| authorships[0].institutions[0].display_name | Yonsei University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Byoung Chul Cho |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea |
| authorships[1].author.id | https://openalex.org/A5100638261 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5124-7132 |
| authorships[1].author.display_name | Dong‐Wan Kim |
| authorships[1].countries | KR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2802835388 |
| authorships[1].affiliations[0].raw_affiliation_string | Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea |
| authorships[1].institutions[0].id | https://openalex.org/I2802835388 |
| authorships[1].institutions[0].ror | https://ror.org/01z4nnt86 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2802835388 |
| authorships[1].institutions[0].country_code | KR |
| authorships[1].institutions[0].display_name | Seoul National University Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Dong-Wan Kim |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea |
| authorships[2].author.id | https://openalex.org/A5044613951 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1303-0447 |
| authorships[2].author.display_name | Alexander I. Spira |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210122908 |
| authorships[2].affiliations[0].raw_affiliation_string | Virginia Cancer Specialists Research Institute, US Oncology Research, Fairfax, VA, USA |
| authorships[2].institutions[0].id | https://openalex.org/I4210122908 |
| authorships[2].institutions[0].ror | https://ror.org/03tbabt10 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210122908 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Virginia Cancer Specialists |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Alexander I. Spira |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Virginia Cancer Specialists Research Institute, US Oncology Research, Fairfax, VA, USA |
| authorships[3].author.id | https://openalex.org/A5012122212 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-6859-363X |
| authorships[3].author.display_name | Jorge Gómez |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I98704320 |
| authorships[3].affiliations[0].raw_affiliation_string | Icahn School of Medicine at Mount Sinai, New York, NY, USA |
| authorships[3].institutions[0].id | https://openalex.org/I98704320 |
| authorships[3].institutions[0].ror | https://ror.org/04a9tmd77 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I1320796813, https://openalex.org/I98704320 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Icahn School of Medicine at Mount Sinai |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jorge E. Gomez |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Icahn School of Medicine at Mount Sinai, New York, NY, USA |
| authorships[4].author.id | https://openalex.org/A5064494204 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3114-1909 |
| authorships[4].author.display_name | Eric B. Haura |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I3019308854 |
| authorships[4].affiliations[0].raw_affiliation_string | H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA |
| authorships[4].institutions[0].id | https://openalex.org/I3019308854 |
| authorships[4].institutions[0].ror | https://ror.org/01xf75524 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I3019308854 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Moffitt Cancer Center |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Eric B. Haura |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA |
| authorships[5].author.id | https://openalex.org/A5046400988 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1065-8095 |
| authorships[5].author.display_name | Sang‐We Kim |
| authorships[5].countries | KR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I116631150, https://openalex.org/I2801680663, https://openalex.org/I40542001 |
| authorships[5].affiliations[0].raw_affiliation_string | Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea |
| authorships[5].institutions[0].id | https://openalex.org/I2801680663 |
| authorships[5].institutions[0].ror | https://ror.org/03s5q0090 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2801680663, https://openalex.org/I4210167194 |
| authorships[5].institutions[0].country_code | KR |
| authorships[5].institutions[0].display_name | Asan Medical Center |
| authorships[5].institutions[1].id | https://openalex.org/I116631150 |
| authorships[5].institutions[1].ror | https://ror.org/02tec3785 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I116631150 |
| authorships[5].institutions[1].country_code | KR |
| authorships[5].institutions[1].display_name | Ulsan College |
| authorships[5].institutions[2].id | https://openalex.org/I40542001 |
| authorships[5].institutions[2].ror | https://ror.org/02c2f8975 |
| authorships[5].institutions[2].type | education |
| authorships[5].institutions[2].lineage | https://openalex.org/I40542001 |
| authorships[5].institutions[2].country_code | KR |
| authorships[5].institutions[2].display_name | University of Ulsan |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Sang-We Kim |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea |
| authorships[6].author.id | https://openalex.org/A5005462156 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-0542-6054 |
| authorships[6].author.display_name | Rachel E. Sanborn |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2801670537 |
| authorships[6].affiliations[0].raw_affiliation_string | Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA |
| authorships[6].institutions[0].id | https://openalex.org/I2801670537 |
| authorships[6].institutions[0].ror | https://ror.org/015tmw922 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2801670537, https://openalex.org/I4210160466, https://openalex.org/I94396219 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Providence Portland Medical Center |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Rachel E. Sanborn |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA |
| authorships[7].author.id | https://openalex.org/A5110482528 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Eun Kyung Cho |
| authorships[7].countries | KR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210088426 |
| authorships[7].affiliations[0].raw_affiliation_string | Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea |
| authorships[7].institutions[0].id | https://openalex.org/I4210088426 |
| authorships[7].institutions[0].ror | https://ror.org/005nteb15 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I12832649, https://openalex.org/I4210088426 |
| authorships[7].institutions[0].country_code | KR |
| authorships[7].institutions[0].display_name | Gachon University Gil Medical Center |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Eun Kyung Cho |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea |
| authorships[8].author.id | https://openalex.org/A5005962138 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-7830-5950 |
| authorships[8].author.display_name | Ki Hyeong Lee |
| authorships[8].countries | KR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210161026 |
| authorships[8].affiliations[0].raw_affiliation_string | Chungbuk National University Hospital, Cheongju, Republic of Korea |
| authorships[8].institutions[0].id | https://openalex.org/I4210161026 |
| authorships[8].institutions[0].ror | https://ror.org/05529q263 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210161026 |
| authorships[8].institutions[0].country_code | KR |
| authorships[8].institutions[0].display_name | Chungbuk National University Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Ki Hyeong Lee |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Chungbuk National University Hospital, Cheongju, Republic of Korea |
| authorships[9].author.id | https://openalex.org/A5073795960 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-9339-7101 |
| authorships[9].author.display_name | Anna Minchom |
| authorships[9].countries | GB |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I142947616 |
| authorships[9].affiliations[0].raw_affiliation_string | Drug Development Unit, Royal Marsden/Institute of Cancer Research, Sutton, UK |
| authorships[9].institutions[0].id | https://openalex.org/I142947616 |
| authorships[9].institutions[0].ror | https://ror.org/043jzw605 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I142947616 |
| authorships[9].institutions[0].country_code | GB |
| authorships[9].institutions[0].display_name | Institute of Cancer Research |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Anna Minchom |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Drug Development Unit, Royal Marsden/Institute of Cancer Research, Sutton, UK |
| authorships[10].author.id | https://openalex.org/A5008751948 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-7945-2530 |
| authorships[10].author.display_name | Jong Seok Lee |
| authorships[10].countries | KR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I2803058125 |
| authorships[10].affiliations[0].raw_affiliation_string | Seoul National University Bundang Hospital, Seongnam, Republic of Korea |
| authorships[10].institutions[0].id | https://openalex.org/I2803058125 |
| authorships[10].institutions[0].ror | https://ror.org/00cb3km46 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I2802835388, https://openalex.org/I2803058125 |
| authorships[10].institutions[0].country_code | KR |
| authorships[10].institutions[0].display_name | Seoul National University Bundang Hospital |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Jong-Seok Lee |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Seoul National University Bundang Hospital, Seongnam, Republic of Korea |
| authorships[11].author.id | https://openalex.org/A5023055777 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5033-0006 |
| authorships[11].author.display_name | Ji‐Youn Han |
| authorships[11].countries | KR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210120052 |
| authorships[11].affiliations[0].raw_affiliation_string | National Cancer Center, Gyeonggi-do, Republic of Korea |
| authorships[11].institutions[0].id | https://openalex.org/I4210120052 |
| authorships[11].institutions[0].ror | https://ror.org/02tsanh21 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I1290491151, https://openalex.org/I2801339556, https://openalex.org/I4210120052 |
| authorships[11].institutions[0].country_code | KR |
| authorships[11].institutions[0].display_name | National Cancer Center |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Ji-Youn Han |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | National Cancer Center, Gyeonggi-do, Republic of Korea |
| authorships[12].author.id | https://openalex.org/A5060083195 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5308-615X |
| authorships[12].author.display_name | Misako Nagasaka |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I204250578 |
| authorships[12].affiliations[0].raw_affiliation_string | University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA |
| authorships[12].institutions[0].id | https://openalex.org/I204250578 |
| authorships[12].institutions[0].ror | https://ror.org/04gyf1771 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I204250578 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | University of California, Irvine |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Misako Nagasaka |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA |
| authorships[13].author.id | https://openalex.org/A5024203424 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-1556-1543 |
| authorships[13].author.display_name | Joshua K. Sabari |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I57206974 |
| authorships[13].affiliations[0].raw_affiliation_string | New York University School of Medicine, New York, NY, USA |
| authorships[13].institutions[0].id | https://openalex.org/I57206974 |
| authorships[13].institutions[0].ror | https://ror.org/0190ak572 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I57206974 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | New York University |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Joshua K. Sabari |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | New York University School of Medicine, New York, NY, USA |
| authorships[14].author.id | https://openalex.org/A5087923582 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-1764-4975 |
| authorships[14].author.display_name | Sai‐Hong Ignatius Ou |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I204250578 |
| authorships[14].affiliations[0].raw_affiliation_string | University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA |
| authorships[14].institutions[0].id | https://openalex.org/I204250578 |
| authorships[14].institutions[0].ror | https://ror.org/04gyf1771 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I204250578 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | University of California, Irvine |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Sai-Hong Ignatius Ou |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA |
| authorships[15].author.id | https://openalex.org/A5067727178 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Patricia Lorenzini |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210151386 |
| authorships[15].affiliations[0].raw_affiliation_string | Janssen R&D, Spring House, PA, USA |
| authorships[15].institutions[0].id | https://openalex.org/I4210151386 |
| authorships[15].institutions[0].ror | https://ror.org/05af73403 |
| authorships[15].institutions[0].type | company |
| authorships[15].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I4210151386 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Janssen (United States) |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Patricia Lorenzini |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Janssen R&D, Spring House, PA, USA |
| authorships[16].author.id | https://openalex.org/A5062034160 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-4193-841X |
| authorships[16].author.display_name | Joshua Bauml |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210151386 |
| authorships[16].affiliations[0].raw_affiliation_string | Janssen R&D, Spring House, PA, USA |
| authorships[16].institutions[0].id | https://openalex.org/I4210151386 |
| authorships[16].institutions[0].ror | https://ror.org/05af73403 |
| authorships[16].institutions[0].type | company |
| authorships[16].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I4210151386 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Janssen (United States) |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Joshua M. Bauml |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Janssen R&D, Spring House, PA, USA |
| authorships[17].author.id | https://openalex.org/A5107393990 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Joshua C. Curtin |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210151386 |
| authorships[17].affiliations[0].raw_affiliation_string | Janssen R&D, Spring House, PA, USA |
| authorships[17].institutions[0].id | https://openalex.org/I4210151386 |
| authorships[17].institutions[0].ror | https://ror.org/05af73403 |
| authorships[17].institutions[0].type | company |
| authorships[17].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I4210151386 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Janssen (United States) |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Joshua C. Curtin |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Janssen R&D, Spring House, PA, USA |
| authorships[18].author.id | https://openalex.org/A5027461408 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Amy Roshak |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210151386 |
| authorships[18].affiliations[0].raw_affiliation_string | Janssen R&D, Spring House, PA, USA |
| authorships[18].institutions[0].id | https://openalex.org/I4210151386 |
| authorships[18].institutions[0].ror | https://ror.org/05af73403 |
| authorships[18].institutions[0].type | company |
| authorships[18].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I4210151386 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | Janssen (United States) |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Amy Roshak |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Janssen R&D, Spring House, PA, USA |
| authorships[19].author.id | https://openalex.org/A5103144742 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Grace Gao |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I4210151386 |
| authorships[19].affiliations[0].raw_affiliation_string | Janssen R&D, Spring House, PA, USA |
| authorships[19].institutions[0].id | https://openalex.org/I4210151386 |
| authorships[19].institutions[0].ror | https://ror.org/05af73403 |
| authorships[19].institutions[0].type | company |
| authorships[19].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I4210151386 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | Janssen (United States) |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Grace Gao |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Janssen R&D, Spring House, PA, USA |
| authorships[20].author.id | https://openalex.org/A5101998977 |
| authorships[20].author.orcid | https://orcid.org/0000-0001-7016-6696 |
| authorships[20].author.display_name | John Xie |
| authorships[20].countries | US |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I4210151386 |
| authorships[20].affiliations[0].raw_affiliation_string | Janssen R&D, Spring House, PA, USA |
| authorships[20].institutions[0].id | https://openalex.org/I4210151386 |
| authorships[20].institutions[0].ror | https://ror.org/05af73403 |
| authorships[20].institutions[0].type | company |
| authorships[20].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I4210151386 |
| authorships[20].institutions[0].country_code | US |
| authorships[20].institutions[0].display_name | Janssen (United States) |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | John Xie |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Janssen R&D, Spring House, PA, USA |
| authorships[21].author.id | https://openalex.org/A5034407359 |
| authorships[21].author.orcid | |
| authorships[21].author.display_name | Meena Thayu |
| authorships[21].countries | US |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I4210151386 |
| authorships[21].affiliations[0].raw_affiliation_string | Janssen R&D, Spring House, PA, USA |
| authorships[21].institutions[0].id | https://openalex.org/I4210151386 |
| authorships[21].institutions[0].ror | https://ror.org/05af73403 |
| authorships[21].institutions[0].type | company |
| authorships[21].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I4210151386 |
| authorships[21].institutions[0].country_code | US |
| authorships[21].institutions[0].display_name | Janssen (United States) |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Meena Thayu |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Janssen R&D, Spring House, PA, USA |
| authorships[22].author.id | https://openalex.org/A5042316451 |
| authorships[22].author.orcid | |
| authorships[22].author.display_name | Roland E. Knoblauch |
| authorships[22].countries | US |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I4210151386 |
| authorships[22].affiliations[0].raw_affiliation_string | Janssen R&D, Spring House, PA, USA |
| authorships[22].institutions[0].id | https://openalex.org/I4210151386 |
| authorships[22].institutions[0].ror | https://ror.org/05af73403 |
| authorships[22].institutions[0].type | company |
| authorships[22].institutions[0].lineage | https://openalex.org/I1330063522, https://openalex.org/I4210151386 |
| authorships[22].institutions[0].country_code | US |
| authorships[22].institutions[0].display_name | Janssen (United States) |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Roland E. Knoblauch |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Janssen R&D, Spring House, PA, USA |
| authorships[23].author.id | https://openalex.org/A5030107272 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-4846-7449 |
| authorships[23].author.display_name | Keunchil Park |
| authorships[23].countries | KR |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I2802194831, https://openalex.org/I848706 |
| authorships[23].affiliations[0].raw_affiliation_string | Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea |
| authorships[23].institutions[0].id | https://openalex.org/I2802194831 |
| authorships[23].institutions[0].ror | https://ror.org/05a15z872 |
| authorships[23].institutions[0].type | healthcare |
| authorships[23].institutions[0].lineage | https://openalex.org/I2250650973, https://openalex.org/I2802194831 |
| authorships[23].institutions[0].country_code | KR |
| authorships[23].institutions[0].display_name | Samsung Medical Center |
| authorships[23].institutions[1].id | https://openalex.org/I848706 |
| authorships[23].institutions[1].ror | https://ror.org/04q78tk20 |
| authorships[23].institutions[1].type | education |
| authorships[23].institutions[1].lineage | https://openalex.org/I848706 |
| authorships[23].institutions[1].country_code | KR |
| authorships[23].institutions[1].display_name | Sungkyunkwan University |
| authorships[23].author_position | last |
| authorships[23].raw_author_name | Keunchil Park |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.nature.com/articles/s41591-023-02554-7.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10417 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Lung Cancer Treatments and Mutations |
| related_works | https://openalex.org/W2804490319, https://openalex.org/W3164824741, https://openalex.org/W2768684245, https://openalex.org/W2593927093, https://openalex.org/W2990912223, https://openalex.org/W1987273470, https://openalex.org/W2142415310, https://openalex.org/W2910926762, https://openalex.org/W1666348496, https://openalex.org/W2892178176 |
| cited_by_count | 86 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 46 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 35 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 5 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1038/s41591-023-02554-7 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S203256638 |
| best_oa_location.source.issn | 1078-8956, 1546-170X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1078-8956 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Nature Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310319908 |
| best_oa_location.source.host_organization_name | Nature Portfolio |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.nature.com/articles/s41591-023-02554-7.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Nature Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s41591-023-02554-7 |
| primary_location.id | doi:10.1038/s41591-023-02554-7 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S203256638 |
| primary_location.source.issn | 1078-8956, 1546-170X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1078-8956 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Nature Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310319908 |
| primary_location.source.host_organization_name | Nature Portfolio |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319908, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Nature Portfolio, Springer Nature |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.nature.com/articles/s41591-023-02554-7.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Nature Medicine |
| primary_location.landing_page_url | https://doi.org/10.1038/s41591-023-02554-7 |
| publication_date | 2023-09-14 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2007528734, https://openalex.org/W2920175805, https://openalex.org/W2132157071, https://openalex.org/W2166084034, https://openalex.org/W2111662961, https://openalex.org/W2096198395, https://openalex.org/W7075716762, https://openalex.org/W2160982674, https://openalex.org/W2747965175, https://openalex.org/W2770828094, https://openalex.org/W6892106064, https://openalex.org/W2990041408, https://openalex.org/W6967040437, https://openalex.org/W4288459215, https://openalex.org/W2976334328, https://openalex.org/W3043250176, https://openalex.org/W2885289995, https://openalex.org/W2898359687, https://openalex.org/W1546552389, https://openalex.org/W2569357796, https://openalex.org/W2413097448, https://openalex.org/W2790922923, https://openalex.org/W3017413818, https://openalex.org/W4280533169, https://openalex.org/W6650358810, https://openalex.org/W2130629599, https://openalex.org/W4252867417, https://openalex.org/W2403476749, https://openalex.org/W3153403308, https://openalex.org/W3046880985, https://openalex.org/W3024670790, https://openalex.org/W2947479209, https://openalex.org/W4281750842, https://openalex.org/W3191219220, https://openalex.org/W3206539120, https://openalex.org/W3204109254, https://openalex.org/W2140980839, https://openalex.org/W4297982030, https://openalex.org/W3004905091, https://openalex.org/W2977776394, https://openalex.org/W4200552898, https://openalex.org/W4310754365, https://openalex.org/W4379281113, https://openalex.org/W3088596048, https://openalex.org/W4281773631, https://openalex.org/W3204399134, https://openalex.org/W2089716357, https://openalex.org/W2949398488, https://openalex.org/W2155933329, https://openalex.org/W2094897484, https://openalex.org/W3003499321 |
| referenced_works_count | 51 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 97 |
| corresponding_author_ids | https://openalex.org/A5064697305 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 24 |
| corresponding_institution_ids | https://openalex.org/I193775966 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8500000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.99724565 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |